Q2-osavuosiraportti
Vain PDF
18 päivää sitten
Tarjoustasot
First North Denmark
Määrä
Osto
20 000
Myynti
Määrä
8 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
-VWAP
Alin
-Vaihto ()
VWAP
Ylin
-Alin
-Vaihto ()
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q2-osavuosiraportti | 29.8. | |
| 2024 Yhtiökokous | 10.4. | |
| 2024 Q4-osavuosiraportti | 7.3. | |
| 2024 Q2-osavuosiraportti | 29.8.2024 | |
| 2023 Yhtiökokous | 29.4.2024 |
Datan lähde: Millistream, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
10.9.·Think Monsenso has got a huge giant competitor in AL, wonder if the idea of a health portal is about to be overtaken by something much bigger?
11.9.·Depends on the management and the board - they are the ones who set the direction. If their mobile app can do no more than be a questionnaire and a heart rate monitor - and you completely neglect the possibilities with AI - then they ARE over the moon. But the shareholders know nothing about the product and what it "can" - they still use images of their mobile app in presentations that are many years old. And then they inform the market twice a year about their poor financial figures and missed KPIs. And nothing else.- 10.9.·In a little while, Mon(NON)senso will fall by about 15% because someone is going to sell 1,000 shares, for the tidy sum of 212 DKK. ... why ... do you need to sell for 212 DKK? Then instead, sell the crap all the way down to a 5-øre ... But again, the management probably doesn't care. They got a new Certified advisor in April 2024 - that hasn't helped much. They (Monsenso) haven't even updated their "investor brochure" - which can be accessed on the first page of their "investor relations" online with - who is the new Certified advisor :) - their investor brochure is generally from 2023 ... with the board of directors and all that ... hehe ... Seriously! Get your act together.11.9.·Agree - the tax deal is probably the best way to get something out of it. There is just an issue with liquidity if there are many to be traded. Monsenso has been happy to receive from shareholders - but does nothing to promote shareholder value.
- 5.9.·No, I don't understand that stock either, I know many people who have lost large sums of money on that stock, especially when they were just starting out, I've been in dialogue with them, they weren't nice guys back then.8.9.·They simply don't understand being a "listed" company. And that's all the way around. The board of directors should have been replaced by the executive board long ago since KPIs are repeatedly not being met. The existing shareholders can't do anything - and with the liquidity they have right now, they can't vote with their feet either.
1.9.·Funny how they keep going to the market for new money, but at the same time want to maintain high salaries for themselves. And even more stupidly people still give them money2.9.·That being said, and if you look at the potential market for digital health solutions AND the company's stated mission - there is still potential. Unfortunately, Monsenso is bad at meeting their KPIs and they are completely unmanageably bad at handling investor relations. And those are just 2 things you can't be "new" to the capital market.- 29.8.·2025 H1: I think the management and board of directors of Monsenso live in a different reality - where creating shareholder value is NOT on the agenda. Business development: We are happy to be able to report on the results and development in the first half of 2025. Our continued commitment to innovation and strategic growth has resulted in significant progress across several areas. Are we happy? significant progress? Seriously? The reality is: the share has lost 40% YTD. The liquidity for the share is almost non-existent. Revenue is lower than expected. There is NO comment on this. They call themselves a growth company - and we should not project much before capital is needed. And they are already in the process of completely cutting themselves off from the stock market. And they are continuing to do so. What about some commitment? When did the management and board of directors last buy shares in Monsenso? They would like to be granted warrants, but buy shares themselves in the market ... Nope!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Q2-osavuosiraportti
Vain PDF
18 päivää sitten
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- 10.9.·Think Monsenso has got a huge giant competitor in AL, wonder if the idea of a health portal is about to be overtaken by something much bigger?11.9.·Depends on the management and the board - they are the ones who set the direction. If their mobile app can do no more than be a questionnaire and a heart rate monitor - and you completely neglect the possibilities with AI - then they ARE over the moon. But the shareholders know nothing about the product and what it "can" - they still use images of their mobile app in presentations that are many years old. And then they inform the market twice a year about their poor financial figures and missed KPIs. And nothing else.
- 10.9.·In a little while, Mon(NON)senso will fall by about 15% because someone is going to sell 1,000 shares, for the tidy sum of 212 DKK. ... why ... do you need to sell for 212 DKK? Then instead, sell the crap all the way down to a 5-øre ... But again, the management probably doesn't care. They got a new Certified advisor in April 2024 - that hasn't helped much. They (Monsenso) haven't even updated their "investor brochure" - which can be accessed on the first page of their "investor relations" online with - who is the new Certified advisor :) - their investor brochure is generally from 2023 ... with the board of directors and all that ... hehe ... Seriously! Get your act together.11.9.·Agree - the tax deal is probably the best way to get something out of it. There is just an issue with liquidity if there are many to be traded. Monsenso has been happy to receive from shareholders - but does nothing to promote shareholder value.
- 5.9.·No, I don't understand that stock either, I know many people who have lost large sums of money on that stock, especially when they were just starting out, I've been in dialogue with them, they weren't nice guys back then.8.9.·They simply don't understand being a "listed" company. And that's all the way around. The board of directors should have been replaced by the executive board long ago since KPIs are repeatedly not being met. The existing shareholders can't do anything - and with the liquidity they have right now, they can't vote with their feet either.
- 1.9.·Funny how they keep going to the market for new money, but at the same time want to maintain high salaries for themselves. And even more stupidly people still give them money2.9.·That being said, and if you look at the potential market for digital health solutions AND the company's stated mission - there is still potential. Unfortunately, Monsenso is bad at meeting their KPIs and they are completely unmanageably bad at handling investor relations. And those are just 2 things you can't be "new" to the capital market.
- 29.8.·2025 H1: I think the management and board of directors of Monsenso live in a different reality - where creating shareholder value is NOT on the agenda. Business development: We are happy to be able to report on the results and development in the first half of 2025. Our continued commitment to innovation and strategic growth has resulted in significant progress across several areas. Are we happy? significant progress? Seriously? The reality is: the share has lost 40% YTD. The liquidity for the share is almost non-existent. Revenue is lower than expected. There is NO comment on this. They call themselves a growth company - and we should not project much before capital is needed. And they are already in the process of completely cutting themselves off from the stock market. And they are continuing to do so. What about some commitment? When did the management and board of directors last buy shares in Monsenso? They would like to be granted warrants, but buy shares themselves in the market ... Nope!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
20 000
Myynti
Määrä
8 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
-VWAP
Alin
-Vaihto ()
VWAP
Ylin
-Alin
-Vaihto ()
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q2-osavuosiraportti | 29.8. | |
| 2024 Yhtiökokous | 10.4. | |
| 2024 Q4-osavuosiraportti | 7.3. | |
| 2024 Q2-osavuosiraportti | 29.8.2024 | |
| 2023 Yhtiökokous | 29.4.2024 |
Datan lähde: Millistream, Quartr
Q2-osavuosiraportti
Vain PDF
18 päivää sitten
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q2-osavuosiraportti | 29.8. | |
| 2024 Yhtiökokous | 10.4. | |
| 2024 Q4-osavuosiraportti | 7.3. | |
| 2024 Q2-osavuosiraportti | 29.8.2024 | |
| 2023 Yhtiökokous | 29.4.2024 |
Datan lähde: Millistream, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- 10.9.·Think Monsenso has got a huge giant competitor in AL, wonder if the idea of a health portal is about to be overtaken by something much bigger?11.9.·Depends on the management and the board - they are the ones who set the direction. If their mobile app can do no more than be a questionnaire and a heart rate monitor - and you completely neglect the possibilities with AI - then they ARE over the moon. But the shareholders know nothing about the product and what it "can" - they still use images of their mobile app in presentations that are many years old. And then they inform the market twice a year about their poor financial figures and missed KPIs. And nothing else.
- 10.9.·In a little while, Mon(NON)senso will fall by about 15% because someone is going to sell 1,000 shares, for the tidy sum of 212 DKK. ... why ... do you need to sell for 212 DKK? Then instead, sell the crap all the way down to a 5-øre ... But again, the management probably doesn't care. They got a new Certified advisor in April 2024 - that hasn't helped much. They (Monsenso) haven't even updated their "investor brochure" - which can be accessed on the first page of their "investor relations" online with - who is the new Certified advisor :) - their investor brochure is generally from 2023 ... with the board of directors and all that ... hehe ... Seriously! Get your act together.11.9.·Agree - the tax deal is probably the best way to get something out of it. There is just an issue with liquidity if there are many to be traded. Monsenso has been happy to receive from shareholders - but does nothing to promote shareholder value.
- 5.9.·No, I don't understand that stock either, I know many people who have lost large sums of money on that stock, especially when they were just starting out, I've been in dialogue with them, they weren't nice guys back then.8.9.·They simply don't understand being a "listed" company. And that's all the way around. The board of directors should have been replaced by the executive board long ago since KPIs are repeatedly not being met. The existing shareholders can't do anything - and with the liquidity they have right now, they can't vote with their feet either.
- 1.9.·Funny how they keep going to the market for new money, but at the same time want to maintain high salaries for themselves. And even more stupidly people still give them money2.9.·That being said, and if you look at the potential market for digital health solutions AND the company's stated mission - there is still potential. Unfortunately, Monsenso is bad at meeting their KPIs and they are completely unmanageably bad at handling investor relations. And those are just 2 things you can't be "new" to the capital market.
- 29.8.·2025 H1: I think the management and board of directors of Monsenso live in a different reality - where creating shareholder value is NOT on the agenda. Business development: We are happy to be able to report on the results and development in the first half of 2025. Our continued commitment to innovation and strategic growth has resulted in significant progress across several areas. Are we happy? significant progress? Seriously? The reality is: the share has lost 40% YTD. The liquidity for the share is almost non-existent. Revenue is lower than expected. There is NO comment on this. They call themselves a growth company - and we should not project much before capital is needed. And they are already in the process of completely cutting themselves off from the stock market. And they are continuing to do so. What about some commitment? When did the management and board of directors last buy shares in Monsenso? They would like to be granted warrants, but buy shares themselves in the market ... Nope!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
20 000
Myynti
Määrä
8 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
-VWAP
Alin
-Vaihto ()
VWAP
Ylin
-Alin
-Vaihto ()
Välittäjätilasto
Dataa ei löytynyt